Benyamin Rahmani, PhD, is a MedTech regulatory consultant, board advisor, and former Notified Body assessor with expertise in UK and EU MDR. He helps MedTech founders get high-risk devices approved in the EU and UK first time, avoiding delays and protecting funding timelines. As Founder of MedStride, he works with startups and scaling manufacturers to define clear, defensible regulatory strategies across clinical evaluation, technical documentation, and certification readiness. His approach is grounded in how regulators actually assess submissions, enabling faster, lower-risk market access.

Prior to MedStride, he spent nearly six years as a Senior Assessor and Certification Manager at BSI, a leading EU Notified Body and UK Approved Body. He reviewed 200+ submissions and contributed to approval and refusal decisions for devices entering the EU and UK markets across all device classes, including class III cardiovascular implants. Earlier in his career, he worked across MedTech R&D and clinical practice within the NHS, contributing to implantable device development and transplant procedures. He has authored 20+ peer-reviewed publications and holds a PhD in Biomedical Engineering.